Pathway Advisors Limited won the 2025 BAFI Award for Best Issuing House and Financial Advisory Firm of the Year, recognizing ...

The savings bank industry has expressed disappointment over not receiving any policy-related questions during the Financial Services Commission's audit by the National Assembly's Political Affairs ...

Pathways Advisors Limited (PAL), a leading investment banking and financial advisory firm, bagged the Best Issuing House and Financial Advisory Firm of the Year awards at the 2025 edition of ...

The Business Recovery and Insolvency Practitioners Association of Nigeria (BRIPAN) has provided specialised training for staff of the Nigeria Deposit Insurance Corporation (NDIC) on personal ...

Evernorth’s $1B merger with Armada will create the largest XRP treasury firm on Nasdaq. Ripple, SBI, and Pantera Capital back Evernorth’s bid to expand XRP’s institutional reach. Asheesh Birla, former ...

The NBC News layoffs are expected to affect 100-150 staffers, but employees are being encouraged to apply for open positions.

This ruling underscores the mandatory requirement for incriminating material to sustain additions in a Section 153C search assessment, leading to the deletion of a major bogus Long-Term Capital Gains ...

Television HGTV Made A ‘Cancel’ Joke On New Fall TV Post, And Fans Are All Riled Up Over Their Favorite Shows Getting Axed Again Television A Bunch Of HGTV Stars Have Had To Speak Out As Fans Worried ...

The acquisition of EA for US$55 billion is a continuation of similar consolidation trends that have been seen across the creative sector, including music, film and television.

The new multiyear OEM contracts are expected to increase sales volumes, improve pricing, and generate higher margins, positioning Cleveland-Cliffs for significant growth as automotive sector demand ...

But while Insider reports on when these transactions are done - or announced to the market - there is often scant detail on how they were pieced together, by many different people, over the course of ...

Hims & Hers is emerging as a disruptive force in the obesity treatment market, challenging established GLP-1 drug makers. Read why HIMS stock is a Hold.